Safety and Potential Bioactivity of CLBS16 in Patients With Coronary Microvascular Dysfunction and Without Obstructive Coronary Artery Disease
Clinical trial NCT03508609 · COMPLETED
Trial details
- NCT number
- NCT03508609
- Sponsor
- Lisata Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-19
- Primary completion
- 2019-12-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.